FDA.reportPublic FDA data

MOMETASONE FUROATE

Substance profile for UNII 04201GDN4R, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for MOMETASONE FUROATE
Structure render from PubChem CID 441336

Substance Identity#

UNII
04201GDN4R
Preferred term
MOMETASONE FUROATE
Registry number
83919-23-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C27H30Cl2O6
Chemical structure for MOMETASONE FUROATE
Structure render from PubChem CID 441336

Chemical And Database Identifiers#

InChIKey
WOFMFGQZHJDGCX-ZULDAHANSA-N
SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)CCl
RxCUI
30145
PubChem
441336
NCIt
C29268
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound441336pubchem.ncbi.nlm.nih.gov/compound/441336
PubChem InChIKey SearchWOFMFGQZHJDGCX-ZULDAHANSA-Npubchem.ncbi.nlm.nih.gov/#query=WOFMFGQZHJDGCX-ZULDAHANSA-N
RxNorm30145mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=30145
NCI ThesaurusC29268ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29268
FDA Substance Registration System04201GDN4Rprecision.fda.gov/uniisearch/srs/unii/04201GDN4R

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTMometasone Furoate Ointment 0.1% For dermatologic use only- not for ophthalmic use1
ACTIVE MOIETYMometasone Furoate Ointment 0.1% For dermatologic use only- not for ophthalmic use1
ACTIVE INGREDIENTdb303d11-eba4-49f7-bf9c-7d944ddb43e71
ACTIVE MOIETYdb303d11-eba4-49f7-bf9c-7d944ddb43e71
ACTIVE MOIETYc337bce8-27e9-48fd-85fa-381d0242a36a1
ACTIVE INGREDIENTc337bce8-27e9-48fd-85fa-381d0242a36a1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use NASONEX safely and effectively. See full prescribing information for NASONEX. NASONEX ® (mometasone furoate monohydrate) Nasal Spray 50 mcg † † calculated on the anhydrous basis Initial U.S. Approval: 19971
ACTIVE MOIETYMometasone Furoate Cream 0.1% For Dermatologic Use Only Not for Ophthalmic Use1
ACTIVE INGREDIENTMometasone Furoate Cream 0.1% For Dermatologic Use Only Not for Ophthalmic Use1
ACTIVE MOIETY8c0c49c9-aa28-4587-869e-b403681525402
ACTIVE INGREDIENT8c0c49c9-aa28-4587-869e-b403681525402
ACTIVE INGREDIENTThese highlights do not include all the information needed to use ASMANEX ® TWISTHALER ® safely and effectively. See full prescribing information for ASMANEX TWISTHALER. ASMANEX TWISTHALER 110 mcg, 220 mcg (mometasone furoate inhalation powder) Initial U.S. Approval: 19871
ACTIVE INGREDIENT0edf333a-776d-45b8-b567-acc863f8599b1
ACTIVE INGREDIENTMometasone Furoate Cream USP 0.1%1
ACTIVE MOIETYMOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)2
ACTIVE INGREDIENTMOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)2
ACTIVE INGREDIENTMometasone Furoate Lotion 0.1% (mometasone furoate topical solution USP)1
ACTIVE INGREDIENTDULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE) AEROSOL [MERCK SHARP & DOHME CORP.]24
ACTIVE INGREDIENTASMANEX (MOMETASONE FUROATE) INHALANT [MERCK SHARP & DOHME CORP.]13
ACTIVE INGREDIENTELOCON (MOMETASONE FUROATE) LOTION [MERCK SHARP & DOHME CORP.]10
ACTIVE INGREDIENTELOCON (MOMETASONE FUROATE) CREAM [MERCK SHARP & DOHME CORP.]9
ACTIVE INGREDIENTELOCON (MOMETASONE FUROATE) OINTMENT [MERCK SHARP & DOHME CORP.]9
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [GLENMARK PHARMACEUTICALS INC., USA]5
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]5
ACTIVE INGREDIENTASMANEX HFA (MOMETASONE FUROATE) AEROSOL [MERCK SHARP & DOHME CORP.]4
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]4
ACTIVE INGREDIENTMOMETASONE FUROATE LOTION [GLENMARK PHARMACEUTICALS INC., USA]4
ACTIVE INGREDIENTMOMETASONE FUROATE SOLUTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]4
ACTIVE INGREDIENTMOMETASONE FUROATE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]4
ACTIVE INGREDIENTMOMETASONE FUROATE (MOMETASONE FUROATE) SOLUTION [G&W LABORATORIES, INC.]3
ACTIVE INGREDIENTMOMETASONE FUROATE LOTION [GLOBAL PHARMACEUTIALS, DIVISION OF IMPAX LABORATORIES, INC.]3
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]3
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [GLOBAL PHARMACEURICALS, DIVISION OF IMPAX LABORATORIES, INC.]3
ACTIVE INGREDIENTPROPEL () KIT PROPEL MINI () KIT [INTERSECT ENT, INC.]3
ACTIVE MOIETYPROPEL () KIT PROPEL MINI () KIT [INTERSECT ENT, INC.]3
ACTIVE INGREDIENTMOMETASONE FUROATE (MOMETASONE FUROATE) CREAM [G&W LABORATORIES, INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE (MOMETASONE FUROATE) CREAM [HARRIS PHARMACEUTICAL, INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE (MOMETASONE FUROATE) OINTMENT [G&W LABORATORIES, INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE (MOMETASONE FUROATE) OINTMENT [HARRIS PHARMACEUTICAL, INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE (MOMETASONE FUROATE) SOLUTION [HARRIS PHARMACEUTICAL, INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [GLOBAL PHARMACEURICALS, DIVISION OF IMPAX LABORATORIES, INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [PERRIGO NEW YORK INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [TARO PHARMACEUTICALS U.S.A., INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [PERRIGO NEW YORK INC]2
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
ACTIVE INGREDIENTMOMETASONE FUROATE SOLUTION [PERRIGO NEW YORK INC]2
ACTIVE INGREDIENTCLARO OTIC SOLUTION ((FLORFENICOL, TERBINAFINE, MOMETASONE FUROATE)) SOLUTION [BAYER HEALTHCARE, LLC ANIMAL HEALTH DIVISION]1
ACTIVE INGREDIENTELOCON (MOMETASONE FUROATE) CREAM [A-S MEDICATION SOLUTIONS LLC]1
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [CLINICAL SOLUTIONS WHOLESALE]1
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [PROFICIENT RX LP]1
ACTIVE INGREDIENTMOMETASONE FUROATE CREAM [PROFICIENT RX LP]1
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [REMEDYREPACK INC. ]1
ACTIVE INGREDIENTMOMETASONE FUROATE OINTMENT [REMEDYREPACK INC. ]1
ACTIVE INGREDIENTPOSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1